ABSTRACT BACKGROUND: The number of patients using methotrexate (MTX) has increased during the last decade. Because of the narrow therapeutic range and potential risks of incorrect use, vigilance is required when dispensing MTX. In 2009, the Royal Dutch Pharmacists Society, in accordance with the Dutch Health Care Inspectorate, published safe MTX dispensing recommendations for community pharmacies.
• Methotrexate (MTX) was originally designed as a chemotherapeutic drug in high doses. In low doses, the drug is generally safe; however, serious side effects and toxicity can occur due to overdosing. Serious events, including fatal incidents with MTX, have been reported in several countries.
• Medication errors are a common cause of harm to patients.
Medication errors related to MTX can occur during all phases of use, but these errors often result from confusion about dosing schedules.
What is already known about this subject
• In 2009, the Royal Dutch Pharmacists Society, in accordance with the Dutch Health Care Inspectorate, published safe MTX dispensing recommendations for community pharmacies.
• It is generally known that implementation of guidelines in health care can be difficult.
• Five recommendations showed lower adherence rates (< 75% self-reported adherence of a pharmacy team member): inquiring about the indication with the patient, recording the indication in the pharmacy information system, authorization of MTX dispensing during absence of the pharmacist, patient counseling at second dispensing, and discussion and recording of agreements with general practitioners.
• Self-reported nonadherence to the recommendations for the pharmacy team as a whole was low, but there was large variation within the teams (e.g., pharmacist indicated adherence to a specific recommendation whereas pharmacy technician indicated nonadherence).
• Adherence with working procedures increased significantly from 2008 to 2010, especially the number of dispensed prescriptions with notification of the day of intake on the drug label increased sharply (from 9.9% in 2008 to 77.1% in 2010, P < 0.001).
What this study adds D ue to increased prescribing of methotrexate (MTX) for autoimmune disorders such as rheumatoid arthritis (RA) and psoriasis, the number of MTX users in many Western countries has increased during the past years. [1] [2] [3] [4] [5] [6] This increase is especially a result of changes in the treatment guidelines for management of RA, which now recommend MTX as the first-choice disease modifying antirheumatic drug (DMARD). 7 MTX is an antagonist of folate-dependent enzymes involved in DNA and RNA synthesis and was originally designed as a chemotherapeutic drug in high doses. In low doses, MTX is generally safe; however, serious side effects and toxicity can occur due to overdosing, including hepatotoxicity and ulceration of gastrointestinal and mouth mucosa. 8 In the Netherlands, MTX is registered for the indications RA, plaque psoriasis, and several carcinomas (e.g., trophoblastic tumours, non-Hodgkin's lymphoma, and head and neck tumours). The dosage schedules for treatment of these diseases MTX dispensing based on pharmacy dispensing records was assessed. Data collection was performed in May 2011 by 20 fourth-year master of pharmacy students who were involved in the course "Pharmacy Practice Research" at Utrecht University. All students received instructions on the interview procedure from 1 of the researchers.
Interviews in Pharmacies: Self-reported Adherence with MTX Dispensing Recommendations
To guide the interviews, a structured interview questionnaire-based on the recommendations of the Royal Dutch Pharmaceutical Society 18 -was designed containing mostly closed-ended questions in 4 categories (prescription processing, authorization of dispensing, patient counseling, and multidisciplinary consultations; Table 1 ). Pharmacy team members were asked questions about the adoption of guidelines, and the responses were mostly recorded as yes/no/unclear or on a Likert-scale (never/sometimes/often/most of the time/always). The interviews were pretested with students and researchers involved in the course "Pharmacy Practice Research" at Utrecht University to assess the clarity of questions and to ensure similar interpretation and notation of answers by the different students during the data collection phase. Interviews of pharmacists and pharmacy technicians were adapted to their specific tasks in the pharmacy and were therefore slightly different. In addition, in every pharmacy, a pharmacist was asked to fill out a short questionnaire with general pharmacy characteristics, such as team size and location. In the analysis, besides adherence of pharmacists and other team members, we also assessed adherence for the complete pharmacy team by using the individual answers from the interviewed team members at each pharmacy and calculating guideline adherence for the complete team. The pharmacy team could be completely adherent (all team members indicated adherence to a specific working procedure); the team could be nonadherent (none of the team members indicated following a specific procedure); or there could be variation within the team (some team members working in the same pharmacy indicated adherence in following a guideline, while others did not).
Extraction of Pharmacy Records: Assessment of Adherence to Recommendations
Most patients in the Netherlands are registered at a single community pharmacy; therefore, pharmacy records are virtually complete with regard to outpatient medication use. 19 For this study, we extracted electronic dispensing records of all patients meeting the following inclusion criteria: age > 18 years on January 1, 2008, and filling of ≥ 1 MTX prescription (Anatomical Therapeutical Chemical (ATC) code L04AX03) between December 1, 2010, and May 10, 2011. For all patients meeting these criteria, anonymous dispensing records were extracted for the period from January 1, 2008, to May 10, 2011, differs from "once a day" for the treatment of carcinomas to "once a week" for RA and plaque psoriasis. These different dosing frequencies may lead to confusion, substitution, and misinterpretation of MTX dosage schedules by physicians, pharmacists, and patients. Because of the narrow therapeutic range and potential risks of incorrect use of MTX, vigilance is required when dispensing MTX. 9, 10 Serious events, including fatal incidents with MTX, have been reported in several countries. 8, 9, [11] [12] [13] Improving patient safety is a priority health policy across the world. Previous research shows that medication errors are a common cause of harm to patients. [14] [15] [16] There are many factors that contribute to the complexity of the medication use process in general, and medication errors can therefore occur during all phases of use and can be related to prescriber, dispenser, or patient. 15 Moore et al. (2004) 11 showed that medication errors related to MTX occurred during all phases of use, but these errors often resulted from confusion about dosing schedules.
After urgent requests from the Dutch Health Care Inspectorate, in 2009, the Royal Dutch Pharmaceutical Society (in collaboration with the Medicines Evaluation Board and associations of hospital pharmacists, rheumatologists, dermatologists, and general practitioners) formulated recommendations for community pharmacists to prevent future MTXrelated medication errors. These recommendations included, for example, recording of the day of intake on the medication label and patient counseling about MTX use. 17, 18 These recommendations are shown in Table 1 . The purpose of this study was to explore Dutch community pharmacies' adherence to these national recommendations.
■■ Methods Study Setting
The study was conducted in Dutch community pharmacies belonging to the Utrecht Pharmacy Practice Network for Education and Research (UPPER). This network consists of community pharmacies that regularly participate in research and traineeships for pharmacy students. Approximately 900 community pharmacists in the UPPER network received an e-mail invitation to participate in this study and were asked to respond within 4 weeks. This study was conducted in compliance with the requirements of the UPPER Institutional Review Board of the Pharmacoepidemiology and Clinical Pharmacology division of Utrecht University.
Data Collection
The study consisted of 2 parts in order to gain more insight into community pharmacies' adherence with and implementation of MTX dispensing recommendations. First, we conducted interviews with the pharmacy staff to assess self-reported adherence to the national MTX dispensing recommendations. Second, implementation of working procedures to ensure safe to assess the implementation of the national recommendations for safe MTX dispensing. Only patients with dispensings of MTX in both 2008 and 2010 were included for analysis. Data from a 1-year period before publication of the recommendations (January 1, 2008-December 31, 2008) were compared with records of a 1-year period after publication of the recommendations (February 1, 2010-January 31, 2011), with respect to 2 working procedures: (1) registration of the day of intake on the label and (2) maximum dispensing period of 3 months. The pharmacy records contained the following data: study identification number, date of birth, gender, ATC code, drug name, dispensed amount, (prescribed) daily drug use, date of dispensing, and (dosage) label. Based on the information in the pharmacy records, adherence to the working procedures was calculated (maximum dispensing period [based on dispensed amount and prescribed daily drug use]) and registration of day of intake (based on drug label information). The average proportion of records fulfilling the recommendations was calculated.
Data Analysis
Descriptive statistics were calculated. Chi-square testing was used to study differences in self-reported adherence between groups (e.g., pharmacists and pharmacy technicians). Working procedures based on medication records in 2008 and 2010 were compared with Wilcoxon signed ranks tests (skewed variables). All data were analysed using IBM SPSS for Windows, version 19.0 (SPSS, Inc., Chicago, IL).
■■ Results

Response Rate
Ninety community pharmacies belonging to the UPPER network responded positively within the 4-week response period. Twelve pharmacies were excluded, as they could not participate during the 1-month data collection period (May 2011), resulting in 78 (9%) participating community pharmacies. In total, 95 pharmacists and 337 pharmacy technicians were interviewed in these 78 different community pharmacies ( Figure 1 ). In 52 of these pharmacies, suitable pharmacy dispensing records were collected. General characteristics of participating pharmacies (Table 2) were compared with characteristics of Dutch community pharmacies in general 20 and seemed to be similar with respect to the number of pharmacists employed, participation in a chain or franchise, and degree of urbanization. However, pharmacies included in our study had fewer pharmacy technicians employed (5.1 full-time equivalent [FTE] vs. 5.5 FTE; P = 0.04) and more often had a quality certificate (87.2% vs. 40.6%; P< 0.001) compared with Dutch pharmacies in general.
Self-reported Adherence to Recommendations
For 6 of the 11 items on the questionnaire, self-reported adherence to the recommendations was more than 75% for both pharmacists and pharmacy technicians (Table 3) . Five recommendations showed lower adherence rates: inquiring about 
Recommendations of Royal Dutch Pharmaceutical Society Recommendations Examined in This Study Prescription processing
Always contact physician about indication and dosage when MTX is prescribed once a day Always contact physician about indication and dosage when MTX is prescribed once a day Always inquire about indication when a (repeat) prescription is provided by a general practitioner or nursing home physician Always inquire about indication when a (repeat) prescription is provided by a general practitioner or nursing home physician Record all performed actions with MTX into patient records Record all performed actions with MTX into patient records Never accept prescriptions with "known use" or "use according to schedule" as dosage schedule. Contact physician about schedule. Do not dispense MTX to the patient if the physician does not provide the schedule. Clearly note dosage and day of use on label Maximum dispensing period ≤ 3 months Patient counseling Counsel patients sufficiently about use of MTX Counsel patients sufficiently about use of MTX Authorization Only dispense MTX after authorization by a pharmacist Multidisciplinary consultations Discuss and record agreements about these recommendations with general practitioners in pharmacotherapeutic audit meetings Discuss and record agreements about these recommendations with general practitioners in pharmacotherapeutic audit meetings Not
TABLE 1
Overview of Safe Dispensing Recommendations the indication with the patient, recording the indication in the pharmacy information system, authorization of MTX dispensing during absence of the pharmacist, patient counseling at second dispensing, and discussion and recording of agreements with general practitioners. Table 4 shows self-reported adherence to the recommendations for the pharmacy team as a whole. Higher adherence rates (> 75%) for the pharmacy team as a whole were shown only for 2 recommendations (recording of the day of intake on the label and the moment of authorization by the pharmacist). Nonadherence to the recommendations for the pharmacy team as a whole was low, but there was variation within the teams (e.g., pharmacist indicated adherence to a specific recommendation, whereas pharmacy technician indicated nonadherence).
Implementation of MTX Dispensing Recommendations
To assess the change in MTX working procedures between 2008 (n = 3,452 MTX dispensing records) and 2010 (n = 4,718 MTX dispensing records), 2 recommendations (recording of the day of intake on the medication label and maximum dispensing period of 3 months) were studied (Table 5 ). Adherence to these procedures increased significantly from 2008 to 2010; for example, the number of dispensed prescriptions with notification of the day of intake on the drug label increased sharply (from 9.9% in 2008 to 77.1% in 2010, P < 0.001).
■■ Discussion
In 2009, the Royal Dutch Pharmaceutical Society formulated recommendations for safe dispensing of MTX. The purpose of this study was to investigate how closely these recommendations are followed by Dutch community pharmacists. This study shows that the recommendations regarding MTX dispensing are in general adopted by community pharmacies in the Netherlands. This is in line with results of a study performed in 33 Dutch hospital pharmacies, which showed a high degree of adherence to recommendations regarding MTX dispensing in Dutch hospitals. 21 For some of the recommendations, we showed lower (selfreported) adherence, which might indicate these are the more complex recommendations to implement and appear to be less feasible in daily practice. It is generally known that implementation of guidelines in health care can be difficult. 22, 23 A study of dermatologists' adherence to the guidelines of the Dutch Society of Dermatology and Venereology with respect to MTX treatment for plaque psoriasis also showed discrepancies between guideline recommendations and daily clinical practice (e.g., recommendations regarding liver biopsy after high cumulative doses of MTX are not always followed, as this is a procedure associated with risks for the patient). 24 In the present study, interviewees often gave explanations why a recommendation was not adopted or was addressed in another way. Some pharmacists adapted or modified the recommendations in order to have more workable procedures, such as deriving the indication from the prescription or prescribing physician (e.g., rheumatologist) instead of asking the patient about the indication. Another recommendation that is more difficult to implement was the authorization of prescriptions in the absence of the pharmacist. Although the absence of a pharmacist in the community pharmacy (for a longer period of time) is rare, a more detailed description of individual working procedures might be helpful to ensure continued safe dispensing. Pharmacists should teach their technicians about the most important aspects of MTX authorization to ensure safe dispensing of MTX without preceding authorization of pharmacists before dispensing MTX to the patient in some exceptions (afterwards dispensed prescriptions should always be checked by the pharmacist). For example, a guideline describing an additional check of a second technician might help pharmacy technicians in performing these incidental safe dispensing authorizations. A survey conducted among medical practitioners showed that the majority of doctors claimed to be familiar with and followed clinical guidelines in general. Practical issues were often reasons for nonadherence with clinical guidelines. 25 We showed high levels of adherence (> 75%) with most of the recommendations for both pharmacists and pharmacy technicians. However, when studying the complete pharmacy team, adherence to the recommendations was much lower, indicating inconsistencies within the pharmacy team. To ensure medication safety and prevent patient harm, communication and teamwork are of utmost importance. 26 Therefore, pharmacy team members should make every effort to adhere to all the recommendations and overcome inconsistencies in 
Selection of Study Participants
Self-reported Adherence to MTX Recommendations: Complete Pharmacy Team
Limitations
This study provided valuable information about the integration of national recommendations into community pharmacy health care. Guideline adherence depends on different staff members in the community pharmacy, and by focusing on both pharmacists and pharmacy technicians, we were able to gain insight into differences in adherence rates. We used structured interviews to collect the data, which were carried out by a large number of students. The advantage of these interviews was that the students could rephrase questions if the answers were incomplete or unclear. Although students had received clear instructions, there is a chance of bias because of the different levels of interview skills between students, and there might be differences in interpretation of answers. However, we assume this limitation had only minimal effect because the interview questionnaire was straightforward, and questions were derived directly from the recommendations. Furthermore, selection bias may have affected our results, since participating pharmacies were self-selected (responding to an invitation e-mail). It is reasonable to assume that participating pharmacies were perhaps more motivated and committed to the MTX guideline implementation than those pharmacists who refused to participate. However, general characteristics of the participating pharmacies within the study were similar to community pharmacies in the Netherlands in general, except that the pharmacies participating in our study more often had a quality certificate. Finally, our study was based on Dutch recommendations for safe dispensing, which might hamper the generalizability of our findings to other countries. However, adoption of guidelines and implementation of clinical guidelines or recommendations in health care will be relevant to other countries as well.
■■ Conclusions
Overall, Dutch community pharmacies have been able to implement the national recommendations for MTX dispensing and are adherent to most of them. The more complex recommendations were more likely to result in poor adherence. We showed inconsistencies in adhering to the recommendations between pharmacy team members, which underlines the importance of addressing this issue and discussing recommendations with the team. Previous research has shown that increased adherence to dispensing guidelines seems to improve processes of care with respect to MTX. Further research is necessary to determine the outcome of the implementation of the guidelines in the community pharmacy setting. practice within the team. Pharmacists and pharmacy technicians might sometimes have different perspectives on working procedures. Differences among pharmacy team members might be a result of unclear working procedures and instructions, recently appointed pharmacists and technicians, or less strict maintenance of the procedures. Although differences within teams cannot be completely prevented, a discussion of procedures could contribute to consistency in applying, and attentiveness to, dispensing guidelines.
In addition to assessing self-reported adherence to safe dispensing guidelines, we assessed the adoption of working procedures based on objective data from pharmacy records. Pharmacy staff tended to overestimate adherence to safe dispensing guidelines. Based on pharmacy records (objective measurement of working procedure adoption), in 2010 77% of the prescriptions contained a notification of the day of intake on the medication label, while more than 90% of the pharmacists and pharmacy technicians indicated adherence to this recommendation. Previous studies comparing observational data and self-reported data about adherence to clinical guidelines also showed that self-reported adherence significantly exceeded observed adherence. 27 A recent study carried out in the Netherlands showed that the number of MTX incidents involving patients since publication of the national recommendations has not decreased; however, consequences of these errors for patients seem to be less serious. 28 It is important to stimulate increased adherence to recommendations by community pharmacy staff members, and the use of appropriate support tools such as online databases and easy-to-use-software has been shown to be successful. In their study of nursing home residents, Zarowitz et al. (2012) 29 showed improvement in MTX safety by implementing such interventions as software programming and mandatory staff training in nursing homes. Furthermore, the process of guideline implementation should not be overly time consuming. 
